IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 171 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $733,925 | -31.2% | 161,302 | +6.5% | 0.00% | 0.0% |
| Q2 2023 | $1,066,314 | -30.8% | 151,465 | -40.0% | 0.00% | -50.0% |
| Q1 2023 | $1,541,925 | +24.4% | 252,361 | +30.1% | 0.00% | 0.0% |
| Q4 2022 | $1,239,506 | -33.3% | 193,976 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $1,858,290 | +196.9% | 193,976 | +242.0% | 0.00% | +50.0% |
| Q2 2022 | $626,000 | +2.1% | 56,715 | +54.2% | 0.00% | +100.0% |
| Q1 2022 | $613,000 | -13.5% | 36,789 | -0.9% | 0.00% | 0.0% |
| Q4 2021 | $709,000 | -5.5% | 37,133 | +22.1% | 0.00% | -50.0% |
| Q3 2021 | $750,000 | -5.1% | 30,421 | +0.2% | 0.00% | 0.0% |
| Q2 2021 | $790,000 | -45.4% | 30,349 | -33.6% | 0.00% | -33.3% |
| Q1 2021 | $1,448,000 | -35.8% | 45,738 | -5.9% | 0.00% | -40.0% |
| Q4 2020 | $2,255,000 | -79.5% | 48,598 | -85.5% | 0.01% | -79.2% |
| Q3 2020 | $11,023,000 | +35.5% | 334,837 | +13.0% | 0.02% | +26.3% |
| Q2 2020 | $8,135,000 | -46.8% | 296,352 | -42.0% | 0.02% | -53.7% |
| Q1 2020 | $15,290,000 | -16.0% | 510,742 | -22.3% | 0.04% | +7.9% |
| Q4 2019 | $18,194,000 | -1.4% | 657,321 | -35.2% | 0.04% | -5.0% |
| Q3 2019 | $18,451,000 | +45.7% | 1,013,790 | +96.4% | 0.04% | +48.1% |
| Q2 2019 | $12,660,000 | +2972.8% | 516,303 | +1092.5% | 0.03% | +2600.0% |
| Q1 2019 | $412,000 | +7.6% | 43,295 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $383,000 | +3.5% | 43,295 | +31.5% | 0.00% | 0.0% |
| Q3 2018 | $370,000 | -12.1% | 32,925 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $421,000 | -20.4% | 32,925 | +5.2% | 0.00% | 0.0% |
| Q1 2018 | $529,000 | +150.7% | 31,290 | +18.5% | 0.00% | – |
| Q4 2017 | $211,000 | -3.7% | 26,407 | -6.5% | 0.00% | – |
| Q3 2017 | $219,000 | +5.3% | 28,232 | 0.0% | 0.00% | – |
| Q2 2017 | $208,000 | – | 28,232 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
| Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
| Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
| Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
| Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
| Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
| QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
| Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |